Avita Medical | 1811094D - Biaya Penjualan

Harga Saham
1.20
Perubahan Harian
-0.02 -1.23%
Bulanan
11.63%
Tahunan
-60.40%
Q2 Perkiraan
1.22




Biaya Penjualan Perubahan Tanggal
Accuray USD 116.17M 14.63M 2024-12
Celltrion KRW 402.86B 14.24B 2025-09
Clinuvel Pharmaceuticals AUD 2.64M 1.06M 2025-12
Cochlear AUD 319.2M 160.35M 2025-12
CSL USD 3.87B 2.08B 2025-12
Cspc Pharmaceutical CNY 2.11B 173.58M 2025-12
Deva Holding AS TRY 991.13M 182.81M 2023-09
Divis Laboratories Ltd INR 10.63B 1.23B 2025-12
Kangmei Pharma CNY 1.11B 84.66M 2025-09
Knight Therapeutics CAD 82.22M 1.03M 2025-12
Laboratorios Farma EUR 186.09M 11.06M 2023-12
Mayne Pharma AUD 43.74M 2.67M 2024-06
Medical Developments International AUD 7.09M 4.91M 2025-12
Nanosonics AUD 24.22M 1.11M 2025-12
Neuren Pharmaceuticals AUD 7.45M 6.56M 2025-06
Organigram Holdings CAD 56.93M 20.53M 2025-12
Pacific Edge NZD 280K 0 2024-03
Paradigm Biopharmaceuticals AUD 4.5K 2.62K 2025-12
Pharma Mar EUR 3.77M 1.47M 2025-12
Polynovo AUD 9.02M 3.51M 2025-12
Qiagen NV USD 217.43M 29.65M 2025-12
Ramsay Health Care AUD 3.05B 78.7M 2025-12
ResMed USD 536.28M 21.52M 2025-12
Sartorius EUR 484.6M 46.6M 2026-03
Sino Biopharmaceutical CNY 3.08B 589.65M 2025-06
Telix Pharmaceuticals AUD 221.36M 20.78M 2025-12
Tilray USD 164.37M 8.41M 2025-09
Zealand Pharma A/S 410K 5K 2025-06
Zz Pientze Pharmaceu CNY 1.58B 245.15M 2026-03